IMAC Holdings, Inc. (BACK) Stock Analysis

IMAC Holdings, Inc. (BACK) Healthcare & Pipeline Overview

IMAC Holdings, Inc. operates in the healthcare sector, managing outpatient medical clinics that offer regenerative, orthopedic, and minimally invasive procedures. With a focus on treating sports injuries and musculoskeletal conditions, the company manages 15 clinics across several states, positioning itself in the growing market for non-surgical pain management solutions.

What Is the Investment Thesis for BACK?

IMAC Holdings, Inc. operates in the healthcare sector, specifically within medical care facilities, offering regenerative and minimally invasive procedures. The company's growth potential lies in the increasing demand for non-surgical pain management and regenerative therapies. However, with a negative profit margin of -42693.2% and a negative gross margin of -1838.8%, the company faces significant financial challenges. The company's high beta of 1.70 indicates higher volatility compared to the market. The ability to scale its clinic operations and improve financial performance will be critical for long-term sustainability. The company's success depends on effective marketing, patient acquisition, and efficient management of its 15 clinics.

Based on FMP financials and quantitative analysis

BACK Key Highlights

Operates 15 outpatient medical clinics across six states: Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida.

• Focuses on regenerative, orthopedic, and minimally invasive procedures and therapies.
• Provides treatments for sports injuries, ligament and tendon damage, and other soft tissue conditions.
• Offers physical therapy, spinal decompression, and chiropractic manipulation.
• Trades on the OTC market, indicating higher risk and lower liquidity.

Who Are BACK's Competitors?

BACK is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are BACK's Key Strengths?

Specialized in regenerative and minimally invasive procedures.

• Network of 15 outpatient medical clinics.
• Focus on non-surgical pain management.
• Experienced management team.

What Are BACK's Weaknesses?

Negative profit margin of -42693.2%.

• Negative gross margin of -1838.8%.
• High beta of 1.70 indicates higher volatility.
• Trades on the OTC market, indicating higher risk.

What Could Drive BACK Stock Higher?

Potential partnerships with major healthcare providers in Q3 2026.

• Increasing demand for non-surgical pain management solutions.
• Expansion of regenerative medicine market.

What Are the Key Risks for BACK?

Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Negative profit margin of -42693.2%.
• Negative gross margin of -1838.8%.
• Regulatory changes in the healthcare industry.
• Competition from other medical care facilities.
• High beta of 1.70 indicates higher volatility.

What Are the Growth Opportunities for BACK?

• Expansion into New Markets: IMAC Holdings, Inc. can expand its footprint by opening new clinics in underserved markets. The market for outpatient medical services is growing, with a projected annual growth rate of 5-7% over the next five years. By strategically targeting regions with a high demand for regenerative and minimally invasive procedures, IMAC can increase its revenue and market share. This expansion should be focused on areas with favorable demographics and healthcare infrastructure, with a timeline of 2-3 new clinics per year.
• Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, orthopedic practices, and sports medicine clinics can drive patient referrals and increase brand awareness. Forming strategic alliances with established healthcare providers can provide IMAC with access to a broader patient base and enhance its credibility. These partnerships can be structured as referral agreements, joint ventures, or co-location arrangements. The timeline for establishing these partnerships is ongoing, with continuous efforts to build relationships with key stakeholders.
• Enhancement of Service Offerings: Expanding the range of services offered at IMAC clinics can attract a wider range of patients and increase revenue per patient. This could include adding new regenerative therapies, diagnostic services, or wellness programs. By offering a comprehensive suite of services, IMAC can position itself as a one-stop-shop for musculoskeletal and soft tissue conditions. The timeline for implementing new service offerings is 12-18 months, with a focus on evidence-based therapies and patient demand.
• Telemedicine and Virtual Consultations: Implementing telemedicine services can expand IMAC's reach beyond its physical clinic locations. Virtual consultations can provide patients with convenient access to medical advice and treatment recommendations. Telemedicine can also be used for follow-up appointments and remote monitoring. The market for telemedicine is growing rapidly, with a projected annual growth rate of 20-30% over the next five years. The timeline for launching telemedicine services is 6-12 months, with a focus on user-friendly technology and secure data transmission.
• Targeted Marketing and Branding: Implementing a targeted marketing strategy can increase brand awareness and attract new patients. This could include online advertising, social media marketing, and community outreach programs. By focusing on specific patient demographics and conditions, IMAC can effectively communicate its value proposition and differentiate itself from competitors. The timeline for implementing a targeted marketing strategy is ongoing, with continuous efforts to optimize marketing campaigns and track results.

What Threats Does BACK Face?

• Competition from other medical care facilities.
• Regulatory changes in the healthcare industry.
• Economic downturn affecting patient spending.
• Technological advancements rendering current procedures obsolete.

What Are BACK's Competitive Advantages?

• Specialized expertise in regenerative medicine.
• Established network of outpatient medical clinics.
• Focus on non-surgical alternatives for pain management.

What Does BACK Do?

IMAC Holdings, Inc., founded in 2000 and headquartered in Brentwood, Tennessee, owns, manages, and subleases a chain of medical centers focused on innovative medical advancements and care regeneration. The company operates outpatient medical clinics that provide regenerative, orthopedic, and minimally invasive procedures and therapies. These clinics cater to patients suffering from sports injuries, ligament and tendon damage, and various soft tissue conditions, as well as back, knee, and joint pains. IMAC's service offerings include physical therapy, spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics located in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC's business model centers around providing non-surgical alternatives for pain management and recovery, positioning itself within the evolving landscape of outpatient medical care. The company aims to offer comprehensive treatment plans that integrate various therapies to improve patient outcomes and quality of life. IMAC's focus on regenerative medicine and minimally invasive procedures aligns with the growing demand for less invasive and more holistic healthcare solutions.

What Products and Services Does BACK Offer?

• Owns and manages outpatient medical clinics.
• Subleases space for medical advancements and care regeneration centers.
• Provides regenerative medicine therapies.
• Offers orthopedic procedures.
• Performs minimally invasive procedures.
• Treats sports injuries and soft tissue conditions.
• Provides physical therapy and spinal decompression.
• Offers chiropractic manipulation.

How Does BACK Make Money?

• Generates revenue through patient fees for medical procedures and therapies.
• Manages and subleases clinic space to healthcare providers.
• Focuses on non-surgical alternatives for pain management and recovery.

What Industry Does BACK Operate In?

IMAC Holdings, Inc. operates within the medical care facilities industry, which is experiencing growth due to the aging population and increasing demand for specialized medical services. The market for regenerative medicine is expanding, driven by technological advancements and patient preferences for less invasive treatments. However, the industry is competitive, with numerous players offering similar services. IMAC's success depends on its ability to differentiate itself through specialized expertise, patient outcomes, and efficient operations. The company must also navigate regulatory challenges and adapt to evolving healthcare trends to maintain its market position.

Who Are BACK's Key Customers?

• Individuals with sports-related injuries.
• Patients suffering from ligament and tendon damage.
• Individuals experiencing back, knee, and joint pain.
• Patients seeking non-surgical pain management solutions.

IMAC Holdings, Inc. Financial Trajectory

IMAC Holdings, Inc. (BACK) reported $21K in revenue for Q3 FY2025, reflecting 1314.9% growth compared to the prior quarter. The company recorded a net loss of $3.1M, with diluted EPS of $-1.15.

Company Profile

IMAC Holdings, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Franklin, US. The company is led by CEO Faith Zaslavsky. BACK has traded publicly since 2019.

Return on equity for IMAC Holdings, Inc. stands at 105.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.

IMAC Holdings, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

IMAC Holdings, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 28.7% below estimates on average.

Wall Street analysts project IMAC Holdings, Inc. revenue of about $32.3M for fiscal 2026, with EPS near $-9.90.

The most recent 7 insider filings for IMAC Holdings, Inc. break down as 0 sales and 7 purchases. On net that is roughly 30K shares acquired (about $25K) — insiders putting money in tends to read as conviction.

BACK Financials

BACK Latest News

BACK Analyst Consensus

BACK MoonshotScore

IMAC Holdings, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources